RxDoctor Payments Data

Anisa Lakhani

Family · Plano, TXNPI 1497233340

Payments from drug & device makers

$2,053in general payments, 2019–2025

Across 115 payments — averaging $17.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$307
  • AstraZeneca$248
  • Biohaven Pharmaceuticals, Inc.$196
  • Astellas Pharma US Inc$188
  • Novartis$144
  • AbbVie$141
  • plus $829 from 20 others

What the payments were for

  • Food & beverage$1,95395%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,053 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydralazine Hcl11$281

Paid to pharmacies, not to this prescriber.

Other family in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →